Rates of Upstaging, Between Diagnosis and Surgery, and Clinical Management of Metastatic Cutaneous Squamous Cell Carcinoma: A Case–Control Study
BACKGROUND
Cutaneous squamous cell carcinomas (cSCC) have upstage rates of approximately 10.3% to 11.1%. Data are currently limited on the rate of upstaging for metastatic cSCC.
OBJECTIVE
The aim of this study was to determine the rates of upstaging, between diagnosis and surgery, and differences in management for metastatic and non-metastatic high-risk cSCC.
MATERIALS AND METHODS
This was a retrospective, case–control, single institution, multi-center study. Univariate analysis was used.
RESULTS
Sixty-eight subjects (34 metastatic & 34 non-metastatic) with 69 tumors were included. The overall rate of upstaging was 46.4%. The most common reasons for upstage were undocumented tumor size and under-diagnosis of poor differentiation. There were no differences in rates of upstaging. Preoperative imaging was performed in 43.6% of wide local excisions (WLE) versus 3.3% of Mohs micrographic surgery (MMS; p
Source: Dermatologic Surgery - Category: Dermatology Tags: Original Article Source Type: research
More News: Cancer & Oncology | Carcinoma | Dermatology | Skin | Skin Cancer | Squamous Cell Carcinoma | Study